Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: A randomized, placebo-controlled polysomnographic study

Sleep Medicine

Volumn 11, Issue 9, 2010, Pages 848-856

  Oertel, Wolfgang H ^a   Beneš, Heike ^b,c   Garcia Borreguero, Diego ^d   Högl, Birgit ^e   Poewe, Werner ^e   Montagna, Pasquale ^f   Ferini Strambi, Luigi ^g   Sixel Döring, Friederike ^h   Trenkwalder, Claudia ^h,i   Partinen, Markku ^j   Saletu, Bernd ^k   Polo, Olli ^l   Fichtner, Andreas ^m   Schollmayer, Erwin ^m   Kohnen, Ralf ^n,o   Cassel, Werner ^a   Penzel, Thomas ^p   Stiasny Kolster, Karin ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Somni Bene Institute for Medical Research and Sleep Medicine   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

^d SLEEP RESEARCH INSTITUTE   (Spain)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^f UNIVERSITY OF BOLOGNA   (Italy)

^g VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^h Paracelsus Elena Hospital   (Germany)

ⁱ UNIVERSITY OF GÖTTINGEN   (Germany)

^j Vitalmed Research Centre   (Finland)

^k MEDICAL UNIVERSITY OF VIENNA   (Austria)

^l UNIVERSITY OF TURKU   (Finland)

^m Schwarz Pharma AG   (Germany)

ⁿ RPS   (United Kingdom)

^o UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^p CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

more..

Author keywords

Dopamine agonist; Idiopathic restless legs syndrome; Periodic limb movement; Polysomnography; Rotigotine; Sleep; Transdermal patch

Indexed keywords

PLACEBO; ROTIGOTINE;

ADULT; AGED; APPLICATION SITE REACTION; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT SATISFACTION; PERIODIC LIMB MOVEMENT DISORDER; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESTLESS LEGS SYNDROME; SOMNOLENCE; TRANSDERMAL PATCH; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MOVEMENT; POLYSOMNOGRAPHY; RESTLESS LEGS SYNDROME; SEVERITY OF ILLNESS INDEX; TETRAHYDRONAPHTHALENES; THIOPHENES; TRANSDERMAL PATCH; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79960342024     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2010.02.014     Document Type: Article

References (39)

1. Allen R.P., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., Montplaisir J., et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003, 4:101-119.
2. García-Borreguero D., Egatz R., Winkelmann J., Berger K. Epidemiology of restless legs syndrome: the current status. Sleep Med Rev 2006, 10:153-167.
3. Montplaisir J., Boucher S., Poirier G., Lavigne G., Lapierre O., Lespérance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997, 12:61-65.
4. Atlas Task Force of the American Sleep Disorders Association Recording and scoring leg movements. Sleep 1993, 16:748-759.
5. Pollmächer T., Schulz H. Periodic leg movements (PLM): their relationship to sleep stages. Sleep 1993, 16:572-577.
6. Hornyak M., Feige B., Riemann D., Voderholzer U. Periodic leg movements in sleep and periodic limb movement disorder: prevalence, clinical significance and treatment. Sleep Med Rev 2006, 10:169-177.
7. Nicolas A., Michaud M., Lavigne G., Montplaisir J. The influence of sex, age and sleep/wake state on characteristics of periodic leg movements in restless legs syndrome patients. Clin Neurophysiol 1999, 110:1168-1174.
8. American Academy of Sleep Medicine. International classification of sleep disorders, 2nd ed. Diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine; 2005.
9. Oertel W.H., Trenkwalder C., Zucconi M., Beneš H., García-Borreguero D., Bassetti C., et al. State of the art in restless legs syndrome therapy: practice recommendations for treating restless legs syndrome. Mov Disord 2007, 22(Suppl. 18):S466-S475.
10. Hening W.A. Current guidelines and standards of practice for restless legs syndrome. Am J Med 2007, 120:S22-S27.
11. Trenkwalder C., Hening W.A., Montagna P., Oertel W.H., Allen R.P., Walters A.S., et al. Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord 2008, 23:2267-2302.
12. Allen R.P., Earley C.J. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 1996, 19:205-213.
13. García-Borreguero D., Allen R.P., Beneš H., Earley C., Happe S., Högl B., et al. Augmentation as a treatment complication of restless legs syndrome: concept and management. Mov Disord 2007, 22(Suppl. 18):S476-S484.
14. Reynolds N.A., Wellington K., Easthope S.E. Rotigotine. In Parkinson's disease. CNS Drugs 2005, 19:973-981.
15. Watts R.L., Jankovic J., Waters C., Rajput A., Boroojerdi B., Rao J. Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease. Neurology 2007, 68:272-276.
16. Poewe W.H., Rascol O., Quinn N., Tolosa E., Oertel W.H., Martignoni E., et al. Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial. Lancet Neurol 2007, 6:513-520.
17. Oertel W.H., Beneš H., Garcia-Borreguero D., Geisler P., Högl B., Saletu B., et al. Efficacy of rotigotine transdermal system in severe restless legs syndrome: a randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe. Sleep Med 2008, 9:228-239.
18. Trenkwalder C., Beneš H., Poewe W., Oertel W.H., Garcia-Borreguero D., de Weerd A.W., et al. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2008, 7:595-604.
19. Walters A.S., LeBrocq C., Dhar A., Hening W., Rosen R., Allen R.P., et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003, 4:121-132.
20. National Institute of Mental Health. 028 CGI. Clinical Global Impressions. In: Guy W, editor. ECDEU assessment manual for psychopharmacology. Rockville, MD: National Institute of Mental Health; 1976. p. 217-22.
21. Penzel T., Brandenburg U., Peter J.H., Otto R., Hundemer H.P., Lledo A., et al. A new design of a polysomnography-based multi-center treatment study for the restless legs syndrome. Clin Neurophysiol 2002, 113:571-578.
22. Atlas Task Force of the American Sleep Disorders Association EEG arousals: scoring rules and examples. Sleep 1992, 15:173-184.
23. Kohnen R., Stiasny-Kolster K., Oertel W.H., Beneš H., Trenkwalder C. Severity Rating of Restless Legs Syndrome: validation of the RLS-6 scales. Sleep 2004, 27(abstract Suppl.):A342.
24. Hays R.D., Stewart A.L. Sleep measures. Measuring functioning and well-being: The Medical Outcomes Study approach 1992, 235-259. Duke University Press, Durham, NC. A.L. Stewart, J.E. Ware (Eds.).
25. Kohnen R., Beneš H., Heinrich C.R., Kurella B. Development of the disease-specific Restless Legs Syndrome Quality of Life (RLS-QoL) questionnaire. Mov Disord 2002, 17(Suppl. 5):P743Abs.
26. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991, 14:540-545.
27. Zung W.W. The role of rating scales in the identification and management of the depressed patient in the primary care setting. J Clin Psychiatry 1990, 51(Suppl. 6):72-76.
28. Oertel W.H., Beneš H., García-Borreguero D., Geisler P., Högl B., Trenkwalder C., et al. One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome. Sleep Med 2008, 9:865-873.
29. Hening WA, Allen RP, Ondo WG, Walters AS, Winkelman JW, Becker P, et al. Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled trial in the United States. Mov Disord 2010. doi:10.1002/mds.23157 [Epub ahead of print]. doi:10.1002/mds.23157.
30. García-Borreguero D., Larrosa O., de la Llave Y., Granizo J.J., Allen R. Correlation between rating scales and sleep laboratory measurements in restless legs syndrome. Sleep Med 2004, 5:561-565.
31. Hornyak M., Hundemer H.P., Quail D., Riemann D., Voderholzer U., Trenkwalder C. Relationship of periodic leg movements and severity of restless legs syndrome: a study in unmedicated and medicated patients. Clin Neurophysiol 2007, 118:1532-1537.
32. Trotti L.M., Bliwise D.L., Greer S.A., Sigurdsson A.P., Gudmundsdóttir G.B., Wessel T., et al. Correlates of PLMs variability over multiple nights and impact upon RLS diagnosis. Sleep Med 2009, 10(6):668-671.
33. Allen R., Becker P.M., Bogan R., Schmidt M., Kushida C.A., Fry J.M., et al. Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome. Sleep 2004, 27:907-914.
34. Partinen M., Hirvonen K., Jama L., Alakuijala A., Hublin C., Tamminen I., et al. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study - the PRELUDE study. Sleep Med 2006, 7:407-417.
35. Oertel W.H., Beneš H., Bodenschatz R., Peglau I., Warmuth R., Happe S., et al. Efficacy of cabergoline in restless legs syndrome. A placebo-controlled study with polysomnography (CATOR). Neurology 2006, 67:1040-1046.
36. Wetter T.C., Stiasny K., Winkelmann J., Buhlinger A., Brandenburg U., Penzel T., et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 1999, 52:944-950.
37. García-Borreguero D. Long-term safety and efficacy of rotigotine in idiopathic RLS: 3-year results from a multinational, open-label trial. J Sleep Res 2008, 17(Suppl. 1):113. [abstract P68].
38. Beneš H., García-Borreguero D., Allen R., Kohnen R. Augmentation in long-term therapy of the restless legs syndrome with transdermal rotigotine - a retrospective systematic analysis of two large open-label 1-year trials. Mov Disord 2009, 24(Suppl. 1):S438. [abstract].
39. Quilici S., Abrams K.R., Nicolas A., Martin M., Petit C., Lleu P.-L., et al. Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome. Sleep Med 2008, 9:715-726.